Ticker > Company >

Maitreya Medicare share price

Maitreya Medicare Ltd.

NSE: MAITREYA SECTOR: Hospital & Healthcare Services  10.76 K   1   0

250.20
-5.50 (-2.15%)
NSE: Today, 03:31 PM

Price Summary

Today's High

₹ 250.2

Today's Low

₹ 250.2

52 Week High

₹ 400

52 Week Low

₹ 214.45

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

169.54 Cr.

Enterprise Value

171.16 Cr.

No. of Shares

0.68 Cr.

P/E

89.26

P/B

6.34

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  39.49

CASH

1.91 Cr.

DEBT

3.53 Cr.

Promoter Holding

73.11 %

EPS (TTM)

₹  2.8

Sales Growth

-4.55%

ROE

7.36 %

ROCE

11.37%

Profit Growth

-40.15 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-4.55%
3 YearNA
5 YearNA

Profit Growth

1 Year-40.15%
3 YearNA
5 YearNA

ROE%

1 Year7.36%
3 Year24.63%

ROCE %

1 Year11.37%
3 Year20.52%

Debt/Equity

0.1102

Price to Cash Flow

33.71

Interest Cover Ratio

5.2713

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 73.11 0.00
Sep 2024 73.11 0.00
Mar 2024 73.11 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 24.6268666666667% over the past 3 years.
  • Company has been maintaining healthy ROCE of 20.5244% over the past 3 years.
  • The company has an efficient Cash Conversion Cycle of -24.5377 days.
  • The company has a high promoter holding of 73.11%.

 Limitations

  • The company has shown a poor profit growth of 0% for the Past 3 years.
  • The company has shown a poor revenue growth of 0% for the Past 3 years.
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company is trading at a high PE of 89.26.
  • The company is trading at a high EV/EBITDA of 32.8561.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2023 Mar 2024
Net Sales 11.65 10.6
Total Expenditure 9.09 11.42
Operating Profit 2.56 -0.82
Other Income 0 0.17
Interest 0.13 0.22
Depreciation 0.31 0.32
Exceptional Items 0 0
Profit Before Tax 2.12 -1.18
Tax 0.52 -0.29
Profit After Tax 1.6 -0.89
Adjusted EPS (Rs) 2.36 -1.32

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2023 Mar 2024 Mar 2025
Net Sales 38.48 46.53 44.41
Total Expenditure 31.33 40.37 39.53
Operating Profit 7.15 6.16 4.88
Other Income 0.56 0.22 0.44
Interest 0.57 0.74 0.75
Depreciation 1.27 1.26 1.35
Exceptional Items -0.03 0 0
Profit Before Tax 5.84 4.39 3.22
Tax 1.65 1.21 1.32
Net Profit 4.19 3.17 1.9
Adjusted EPS (Rs.) 7.84 4.16 2.8

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 10.7 12.17 12.09
Total Reserves 3.82 18.08 19.98
Borrowings 4.56 2.7 1.96
Other N/C liabilities 0.67 0.68 0.7
Current liabilities 8 6.87 9.68
Total Liabilities 27.75 40.52 44.41
Assets
Net Block 11.51 10.94 11.97
Capital WIP 0 0 0
Intangible WIP 0 0 0
Investments 0.47 2.59 7.58
Loans & Advances 2.67 5.44 5.98
Other N/C Assets 0.58 0.59 0.52
Current Assets 12.52 20.96 18.37
Total Assets 27.75 40.52 44.41
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2023 Mar 2024 Mar 2025
Profit from operations 5.87 4.39 3.22
Adjustment 1.7 3.16 2.18
Changes in Assets & Liabilities -4.85 -6.03 1.08
Tax Paid -0.31 -1.77 -1.45
Operating Cash Flow 2.42 -0.26 5.03
Investing Cash Flow 0.36 -5.57 -7.2
Financing Cash Flow -1.34 10 -1.58
Net Cash Flow 1.43 4.18 -3.75

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Sep 2024% Mar 2025%
promoters 73.11 73.11 73.11
narendra singh tanwar 47.02 47.02 47.02
pranav rohitbhai thaker 15.66 15.66 15.66
vimalkumar natverlal pate... 10.43 10.43 10.43
PARTICULARS Mar 2024% Sep 2024% Mar 2025%
investors 26.89 26.89 26.89
hashim yacoobali - 1.00 1.02
south gujarat shares and ... - 1.44 2.27
minerva emerging opportun... 1.98 - -

Annual Reports

Title Link
Title Link
Annual Report 2024

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Maitreya Medicare Stock Price Analysis and Quick Research Report. Is Maitreya Medicare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Maitreya Medicare. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Maitreya Medicare has a PE ratio of 89.2615055297895 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Maitreya Medicare has ROA of 4.4727% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Maitreya Medicare has a Current ratio of 1.8971.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Maitreya Medicare has a ROE of 7.3588%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Maitreya Medicare has a Debt to Equity ratio of 0.1102 which means that the company has low proportion of debt in its capital.

  • Sales growth: Maitreya Medicare has reported revenue growth of -4.5453% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Maitreya Medicare for the current financial year is 10.9945097452922%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Maitreya Medicare is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Maitreya Medicare is Rs 2.803. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Maitreya Medicare in Ticker for free. Also, one can get the intrinsic value of Maitreya Medicare by using Valuation Calculators, which are available with a Finology ONE subscription. 

Maitreya Medicare FAQs

Q1. What is Maitreya Medicare share price today?
Ans: The current share price of Maitreya Medicare is Rs 250.2.

Q2. What is the market capitalisation of Maitreya Medicare?
Ans: Maitreya Medicare has a market capitalisation of Rs 169.53552 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Maitreya Medicare?
Ans: The PE ratio of Maitreya Medicare is 89.2615055297895 and the P/B ratio of Maitreya Medicare is 6.33539617749238, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Maitreya Medicare share?
Ans: The 52-week high share price of Maitreya Medicare is Rs 400, and the 52-week low share price of Maitreya Medicare is Rs 214.45.

Q5. Does Maitreya Medicare pay dividends?
Ans: Currently, Maitreya Medicare does not pay dividends. Dividend yield of Maitreya Medicare is around 0%.

Q6. What are the face value and book value of Maitreya Medicare shares?
Ans: The face value of Maitreya Medicare shares is Rs 10, while the book value per share of Maitreya Medicare is around Rs 39.4924. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Maitreya Medicare?
Ans: Maitreya Medicare has a total debt of Rs 3.533813 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Maitreya Medicare?
Ans: The ROE of Maitreya Medicare is 7.3588% and ROCE of Maitreya Medicare is 11.3738%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Maitreya Medicare a good buy for the long term?
Ans: The Maitreya Medicare long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Maitreya Medicare undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Maitreya Medicare appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Maitreya Medicare’s financials?
Ans: You can review Maitreya Medicare’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Maitreya Medicare
X